1. Home
  2. PCRX vs GLDD Comparison

PCRX vs GLDD Comparison

Compare PCRX & GLDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$22.51

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Great Lakes Dredge & Dock Corporation

GLDD

Great Lakes Dredge & Dock Corporation

HOLD

Current Price

$17.00

Market Cap

1.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCRX
GLDD
Founded
2006
1890
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Military/Government/Technical
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
2010
2007

Fundamental Metrics

Financial Performance
Metric
PCRX
GLDD
Price
$22.51
$17.00
Analyst Decision
Strong Buy
Sell
Analyst Count
5
2
Target Price
$37.20
$17.00
AVG Volume (30 Days)
579.3K
1.6M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
107.44
28.57
EPS
0.16
1.08
Revenue
$541,533,000.00
$702,503,000.00
Revenue This Year
$6.78
$5.19
Revenue Next Year
$8.54
$7.56
P/E Ratio
$139.00
$15.74
Revenue Growth
26.04
N/A
52 Week Low
$18.80
$7.97
52 Week High
$27.99
$17.02

Technical Indicators

Market Signals
Indicator
PCRX
GLDD
Relative Strength Index (RSI) 49.29 68.41
Support Level $22.57 $14.60
Resistance Level $23.94 N/A
Average True Range (ATR) 0.79 0.03
MACD -0.07 -0.06
Stochastic Oscillator 49.48 80.00

Price Performance

Historical Comparison
PCRX
GLDD

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About GLDD Great Lakes Dredge & Dock Corporation

Great Lakes Dredge & Dock Corp is a provider of dredging services in the United States. The Company is also fully engaged in expanding its core business into the offshore energy industry. Dredging involves the enhancement or preservation of the navigability of waterways or the protection of shorelines through the removal or replenishment of soil, sand, or rock. Company work generally is to performed in coastal waterways and deep water ports. Its project portfolio includes Coastal Restoration, Coastal Protection, Ports and Harbors, International, and Inland Dredging.

Share on Social Networks: